Apr 1, 2009
By:S. Kent Stephan
It's time for pharma market research to advance science-based decisions and foster judgement calls
 |
Apr 1, 2009
By:Marcee Nelson
How one conversation between a woman and her physician can make or break a brand
|
Apr 1, 2009
From the depths of the Great Recession, Pharm Exec called in pros on all sides of the M&A business to help us deal.
|
Apr 1, 2009
By:Joanna Breitstein
From her start as a physician working in apartheid-era South Africa to the dramatic turnaround and takeover of Millennium, Deborah Dunsire has lived a life that has defied all expectations.
|
Apr 1, 2009
By:Kimberly A. Farrell
Why do so many women opt out, burn out, or transfer out of the healthcare workforce? New research sheds light on this age-old problem.
|
Mar 1, 2009
By:Walter Armstrong
Just when you thought it was safe to go back into M&A, the mega merger returns. What's right about Pfizer-Wyeth, and what's scary.
|
Mar 1, 2009
By:Stephen J. Porth, George P. Sillup
Reporters pass on the typical litany of lightning-rod issues and instead devote more than three-quarters of all coverage in 2008 to drug safety—and the regulators who enforce it.
|
| 
PharmExec Blog
Follow Us
RSS
Bookstore
What's the best managed pharma? Professor Bill Trombetta of Saint Joseph's University attempts to answer the question in Pharm Exec's Industry Audit.
The most respected annual ranking of top 50 pharmaceutical companies by prescription drug sales... Who's in, who's back, and who's out?
Don't miss this Podcast series commemorating the 20th anniversary of HBA's Woman of the Year Award with interviews spanning two decades of change makers.
If you're searching for a new business location, attend the Business Facilities LiveXchange event and learn from location experts, meet with economic developers, and network with peers, all at no cost to you!